Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grogan

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Biochemistry|May 31, 1994
Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active siteM Shou, J Grogan, J A Mancewicz, et al.
Journal of Medical Microbiology|October 16, 2015
Cross-transmission of Escherichia coli producing OXA-181 in hospitalized patients and failure of carbapenemase detection by commercial and in-house PCR assaysT W Boo, E McGrath, J Davitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbetaB A Janowski, M J Grogan, S A Jones, et al.
Molecular Carcinogenesis|December 1, 1996
Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthraceneM Shou, K R Korzekwa, K W Krausz, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor ActivityZahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.
Journal of Medicinal Chemistry|June 16, 2009
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926)Martin R Tremblay, André Lescarbeau, Michael J Grogan, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Biochemistry|May 31, 1994
Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active siteM Shou, J Grogan, J A Mancewicz, et al.
Journal of Medical Microbiology|October 16, 2015
Cross-transmission of Escherichia coli producing OXA-181 in hospitalized patients and failure of carbapenemase detection by commercial and in-house PCR assaysT W Boo, E McGrath, J Davitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbetaB A Janowski, M J Grogan, S A Jones, et al.
Molecular Carcinogenesis|December 1, 1996
Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthraceneM Shou, K R Korzekwa, K W Krausz, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor ActivityZahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.
Journal of Medicinal Chemistry|June 16, 2009
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926)Martin R Tremblay, André Lescarbeau, Michael J Grogan, et al.
Pageof 7